论文部分内容阅读
近距离放疗在宫颈癌治疗中占有重要的地位。目前常用的方法是远程后装高剂量率的近距离放疗。对52例Ⅰb～Ⅳa期宫颈癌接受脉冲式低剂量率(PLDR)近距离放疗者进行了研究。 1992年4月～1996年12月,52例宫颈癌患者接受PLDR近距离放疗,其中6例因随访时间<6个月被排除。52例中,Ⅰb期6例,Ⅱa期3例,Ⅱb期11例,Ⅲa期3例,Ⅲb期14例,Ⅳa期1例,Ⅰb期术后局部复发者8例。鳞癌36例、腺癌8例、腺鳞癌
Brachytherapy plays an important role in the treatment of cervical cancer. At present, the commonly used method is to remotely mount a high dose rate brachytherapy. Fifty-two patients with stage Ⅰb-Ⅳa cervical cancer receiving pulsed low dose rate (PLDR) brachytherapy were studied. From April 1992 to December 1996, 52 patients with cervical cancer received PLDR brachytherapy, 6 of whom were excluded due to follow-up of <6 months. In 52 cases, there were 6 cases of stage Ib, 3 cases of stage IIa, 11 cases of stage IIb, 3 cases of stage IIIa, 14 cases of stage IIIb, 1 case of stage IVa, and 8 cases of local recurrence of stage Ib. 36 cases of squamous cell carcinoma, 8 cases of adenocarcinoma, adenosquamous carcinoma